Financhill
Back

Cullinan Therapeutics Quote, Financials, Valuation and Earnings

Buy
59

CGEM
Cullinan Therapeutics

Last Price:
24.81
Seasonality Move:
13.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Cullinan Therapeutics Price Quote

$24.81
-1.91 (-7.15%)
(Updated: May 16, 2024 at 2:10 PM ET)

Cullinan Therapeutics Key Stats

Buy
59
Cullinan Therapeutics (CGEM) is a Buy

Day range:
$26.63 - $28.11
52-week range:
$7.64 - $30.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.54%

Volume:
709.7K
Avg. volume:
1.1M
1-year change:
168.81%
Market cap:
$1.2B
Revenue:
$0
EPS:
$-3.69

How Much Does Cullinan Therapeutics Make?

Data Unavailable

Is Cullinan Therapeutics Growing As A Company?

Data Unavailable

Cullinan Therapeutics Stock Price Performance

What Is Cullinan Therapeutics 52-Week High & Low?

Cullinan Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cullinan Therapeutics?

Is Cullinan Therapeutics Cash Flow Positive?

  • What Is CGEM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$134.3M
  • What Is Cullinan Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $40.8M
  • What Is Cullinan Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $35.8M

Cullinan Therapeutics Return On Invested Capital

Data Unavailable

Cullinan Therapeutics Earnings Date & Stock Price

Cullinan Therapeutics Competitors

Cullinan Therapeutics Dividend Yield

Data Unavailable

Cullinan Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 44.9%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.13
Upside from Last Price: 23.97%

Major Shareholders

  • How many CGEM shares are owned by institutional investors?
    49.3M CGEM shares are owned by institutional investors
  • How many CGEM shares are owned by insiders?
    2.6M CGEM shares are owned by insiders